- Pathologic diagnosis of any solid tumor
- Incurable cancer, with disease progression following at least 1 therapy with no
further standard treatment available in the opinion of the investigator.
- At least 1 evaluable lesion per RECIST criteria
- Clinically unstable primary or metastatic CNS tumors
- Subjects with known diabetes
- QTc interval greater than 470 ms.